"...Bottom line, I think it's fantastic science, it's fantastic biology, this is great for public health in the short term, and I think the concerns are overblown." Longer term, say about 15 years to 20 years out, Ford said he sees a lot of unanswered questions still regarding GLP-1 drugs and their impact in medtech.
In a Phase I clinical trial, a PYY analog named Y14 peptide was administered subcutaneously every 7 to 14 days
Can I freeze slow cooker GLP-1 friendly meals
Accordingly, in vitro and ex vivo studies have shown that exposure to saxagliptin (135, 136) but not sitagliptin (136), results in altered cardiac electrophysiology and is associated with impaired cardiomyocyte contractility
Why I Tried This Peptide for Sleep A simple peptide that might restore sleep and help with brain aging